Virtu Financial’s KALA BIO KALA Stock Holding History

Virtu Financial’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26K	Buy	3,044 +1,334	+78%	+$28.2K	﹤0.01%	1365
2025 Q4	$48K	Buy	+1,710	New	+$76.6K	﹤0.01%	1309
2024 Q3	–	Sell	-622	Closed	-$221K	–	1627
2024 Q2	$221K	Buy	+622	New	+$206K	0.02%	671
2022 Q4	–	Sell	-26	Closed	-$14K	–	1894
2022 Q3	$14K	Sell	26 -4	-13%	-$3.14K	﹤0.01%	1470
2022 Q2	$22K	Sell	30 -26	-46%	-$40.8K	﹤0.01%	1311
2022 Q1	$194K	Buy	56 +5	+10%	+$13.1K	0.01%	790
2021 Q4	$153K	Buy	+51	New	+$237K	0.02%	943
2020 Q3	–	Sell	-5	Closed	-$135K	–	1294
2020 Q2	$135K	Buy	+5	New	+$142K	0.02%	813
2019 Q4	$87K	Buy	+9	New	+$86.9K	0.01%	1110
2018 Q4	–	Sell	-8	Closed	-$200K	–	1778
2018 Q3	$200K	Buy	+8	New	+$244K	0.01%	1076

Other funds holding KALA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Virtu Financial's KALA Position: Q1 2026 in Review

Virtu Financial increased its KALA BIO (KALA) stake by 78% in Q1 2026, buying an estimated $28.2K and bringing the position to 3,044 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

Virtu Financial first reported a position in KALA in Q3 2018 and has held it in 10 quarters since. The position peaked at $221K in Q2 2024. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

Virtu Financial held 3,044 shares of KALA BIO worth $26K as of Q1 2026.
Virtu Financial bought 1,334 KALA BIO shares in Q1 2026, an estimated $28.2K.
KALA BIO made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1365 holding.
Virtu Financial first reported a position in KALA BIO in Q3 2018 and has held it in 10 quarters since.
Virtu Financial's KALA BIO position peaked at $221K in Q2 2024.
28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.